TPM1 protein, involved in striated muscle contraction, decreased upon therapy (47); this indicates a potential benefit of the therapy as an increase in TPM1 levels has been identified as a systemic pro-aging factor in mouse retina and young mouse models of Alzheimer's disease (48). This evidence concerns the gene TPM1 and Alzheimer disease.